Public-registry site landscape for NCT05441826, a Minimal Change Disease study sponsored by Tenet Medicines. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05441826 (registry record) |
| Sponsor | Tenet Medicines |
| Condition(s) | Minimal Change Disease; Focal Segmental Glomerulosclerosis |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05441826 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →